Financials data is unavailable for this security.
View more
Year on year Merit Medical Systems Inc grew revenues 9.24% from 1.15bn to 1.26bn. In addition the company has reduced the cost of goods sold as a percent of sales, selling, general and administrative expenses as a percent of sales and interest paid as a percent of sales. These improvements contributed to 26.70% net income growth from 74.52m to 94.41m.
| Gross margin | 46.83% |
|---|---|
| Net profit margin | 9.05% |
| Operating margin | 11.52% |
| Return on assets | 5.73% |
|---|---|
| Return on equity | 9.40% |
| Return on investment | 6.32% |
More ▼
Cash flow in USDView more
In 2023, Merit Medical Systems Inc increased its cash reserves by 872.86%, or 528.59m. Cash Flow from Financing totalled 559.27m or 44.48% of revenues. In addition the company generated 145.15m in cash from operations while cash used for investing totalled 175.35m.
| Cash flow per share | 3.70 |
|---|---|
| Price/Cash flow per share | 28.11 |
| Book value per share | 22.71 |
|---|---|
| Tangible book value per share | 9.47 |
More ▼
Balance sheet in USDView more
| Current ratio | 5.36 |
|---|---|
| Quick ratio | 3.82 |
| Total debt/total equity | 0.5671 |
|---|---|
| Total debt/total capital | 0.3619 |
More ▼
Growth rates in USD
Year on year, growth in earnings per share excluding extraordinary items increased 25.21%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
| EPS growth(5 years) | 14.05 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 18.62 |
